Evidence map›Paper›PMID 34489348›Full record

ArticleNeurology2021

Experience of Community Neurologists Providing Care for Patients With Neurodegenerative Illness During the COVID-19 Pandemic.

Roman Ayele, Zachary A Macchi, Megan Dini, Meredith Bock, Maya Katz, Steven Z Pantilat, Jacqueline Jones, Benzi M Kluger

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03076671 (More Than a Movement Disorder), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03076671 nacompletednot on this map

More Than a Movement Disorder: Applying Palliative Care to Parkinson's Disease

TypeinterventionalSponsorUniversity of Colorado, DenverRan2017 to 2020Enrolled783ConditionsParkinson Disease, Parkinsonism, Lewy Body Disease, Supranuclear Palsy, ProgressiveArmsPalliative Care
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Roman AyeleFrom the Denver-Seattle Center of Innovation (R.A.), Rocky Mountain Regional VA Medical Center; Department of Health Systems, Management and Policy (R.A.), Department of Neurology (Z.A.M., M.D.), Department of Internal Medicine (Z.A.M.), and College of Nursing (J.J.), University of Colorado Anschutz Medical Campus, Aurora; Departments of Neurology (M.B., M.K.) and Medicine (S.Z.P.), University of California San Francisco; and Departments of Neurology and Medicine (B.M.K.), University of Rochester Medical Center, NY. Roman.Ayele@va.gov.ORCID 0000-0002-4930-5265
Zachary A MacchiFrom the Denver-Seattle Center of Innovation (R.A.), Rocky Mountain Regional VA Medical Center; Department of Health Systems, Management and Policy (R.A.), Department of Neurology (Z.A.M., M.D.), Department of Internal Medicine (Z.A.M.), and College of Nursing (J.J.), University of Colorado Anschutz Medical Campus, Aurora; Departments of Neurology (M.B., M.K.) and Medicine (S.Z.P.), University of California San Francisco; and Departments of Neurology and Medicine (B.M.K.), University of Rochester Medical Center, NY.
Megan DiniFrom the Denver-Seattle Center of Innovation (R.A.), Rocky Mountain Regional VA Medical Center; Department of Health Systems, Management and Policy (R.A.), Department of Neurology (Z.A.M., M.D.), Department of Internal Medicine (Z.A.M.), and College of Nursing (J.J.), University of Colorado Anschutz Medical Campus, Aurora; Departments of Neurology (M.B., M.K.) and Medicine (S.Z.P.), University of California San Francisco; and Departments of Neurology and Medicine (B.M.K.), University of Rochester Medical Center, NY.
Meredith BockFrom the Denver-Seattle Center of Innovation (R.A.), Rocky Mountain Regional VA Medical Center; Department of Health Systems, Management and Policy (R.A.), Department of Neurology (Z.A.M., M.D.), Department of Internal Medicine (Z.A.M.), and College of Nursing (J.J.), University of Colorado Anschutz Medical Campus, Aurora; Departments of Neurology (M.B., M.K.) and Medicine (S.Z.P.), University of California San Francisco; and Departments of Neurology and Medicine (B.M.K.), University of Rochester Medical Center, NY.
Maya KatzFrom the Denver-Seattle Center of Innovation (R.A.), Rocky Mountain Regional VA Medical Center; Department of Health Systems, Management and Policy (R.A.), Department of Neurology (Z.A.M., M.D.), Department of Internal Medicine (Z.A.M.), and College of Nursing (J.J.), University of Colorado Anschutz Medical Campus, Aurora; Departments of Neurology (M.B., M.K.) and Medicine (S.Z.P.), University of California San Francisco; and Departments of Neurology and Medicine (B.M.K.), University of Rochester Medical Center, NY.
Steven Z PantilatFrom the Denver-Seattle Center of Innovation (R.A.), Rocky Mountain Regional VA Medical Center; Department of Health Systems, Management and Policy (R.A.), Department of Neurology (Z.A.M., M.D.), Department of Internal Medicine (Z.A.M.), and College of Nursing (J.J.), University of Colorado Anschutz Medical Campus, Aurora; Departments of Neurology (M.B., M.K.) and Medicine (S.Z.P.), University of California San Francisco; and Departments of Neurology and Medicine (B.M.K.), University of Rochester Medical Center, NY.
Jacqueline JonesFrom the Denver-Seattle Center of Innovation (R.A.), Rocky Mountain Regional VA Medical Center; Department of Health Systems, Management and Policy (R.A.), Department of Neurology (Z.A.M., M.D.), Department of Internal Medicine (Z.A.M.), and College of Nursing (J.J.), University of Colorado Anschutz Medical Campus, Aurora; Departments of Neurology (M.B., M.K.) and Medicine (S.Z.P.), University of California San Francisco; and Departments of Neurology and Medicine (B.M.K.), University of Rochester Medical Center, NY.
Benzi M KlugerFrom the Denver-Seattle Center of Innovation (R.A.), Rocky Mountain Regional VA Medical Center; Department of Health Systems, Management and Policy (R.A.), Department of Neurology (Z.A.M., M.D.), Department of Internal Medicine (Z.A.M.), and College of Nursing (J.J.), University of Colorado Anschutz Medical Campus, Aurora; Departments of Neurology (M.B., M.K.) and Medicine (S.Z.P.), University of California San Francisco; and Departments of Neurology and Medicine (B.M.K.), University of Rochester Medical Center, NY.ORCID 0000-0002-6259-329X
University of California, San Francisco · US

Funding

More than a Movement Disorder: Applying Palliative Care to Parkinson's Disease and Lewy Body DementiasR01NR016037 · NINR · UNIVERSITY OF ROCHESTER · PI KLUGER, BENZI M · 2016 to 2025
$6.5M
Multidisciplinary Research Training in Palliative CareT32AG044296 · NIA · UNIVERSITY OF COLORADO DENVER · PI STACY M FISCHER, JEAN S KUTNER · 2014 to 2026
$3.3M
Advancing Palliative Care for Older Adults Affected by Neurodegenerative Disease: Parkinsons disease, Alzheimers disease and Related DementiasK02AG062745 · NIA · UNIVERSITY OF ROCHESTER · PI KLUGER, BENZI M · 2020 to 2024
$711k
NIA NIH HHS K02 AG062745NIA NIH HHS T32 AG044296NINR NIH HHS R01 NR016037
6 · The paper itself

Abstract

objectiveHealth care delivery systems transformed rapidly at the beginning of the coronavirus disease 2019 (COVID-19) pandemic to slow the spread of the virus while identifying novel methods for providing care. In many ways, the pandemic affected both persons with neurologic illness and neurologists. This study describes the perspectives and experiences of community neurologists providing care for patients with neurodegenerative illnesses during the COVID-19 pandemic.

methodsWe conducted a qualitative study with 20 community neurologists from a multisite comparative-effectiveness trial of outpatient palliative care from July 23, 2020, to November 11, 2020. Participants were interviewed individually about the impact of the coronavirus disease 2019 (COVID-19) pandemic on their professional and personal lives. Interviews were analyzed with matrix analysis to identify key themes.

resultsFour main themes illustrated the impact of the pandemic on community neurologists: (1) challenges of the current political climate, (2) lack of support for new models of care, (3) being on the frontline of suffering, and (4) clinician self-care. Taken together, the themes capture the unusual environment in which community neurologists practice, the lack of clinician trust among some patients, patient and professional isolation, and opportunities to support quality care delivery.

conclusionsThe COVID-19 pandemic and pandemic politics created an environment that made care provision challenging for community neurologists. Efforts to improve care delivery should proactively work to reduce clinician burnout while incorporating support for new models of care adopted due to the pandemic. TRIAL REGISTRATION INFORMATION: ClinicalTrials.gov identifier: NCT03076671.

Indexed as

COVID-19Neurodegenerative DiseasesNeurologistsHumansOutpatientsQualitative ResearchSARS-CoV-2

Identifiers

PMID34489348
PMCPMC8448550
OpenAlexW3168789215

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.